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Prostaglandins,  released from Kupffer cells, have been 
shown to mediate the increase in hepatic glycogenolysis 
by various stimuli such as zymosan, endotoxin, immune 
complexes, and anaphylotoxin C3a involving  prostaglan- 
din (PG) receptors coupled to phospholipase C via a Go 
protein. PGs also decreased glucagon-stimulated glyco- 
genolysis in hepatocytes by a different signal chain in- 
volving PGE, receptors coupled to adenylate cyclase via 
a Gi protein (EP3  receptors). The source of  the prosta- 
glandins for this latter glucagon-antagonistic  action is 
so far unknown. This study provides evidence that Kupf- 
fer cells may be one source: in Kupffer cells, maintained 
in primary culture for 72 hours, glucagon (0.1 to 10 moll 
L) increased PGE,,  PGF,,,  and PGD,  synthesis rapidly 
and transiently. Maximal prostaglandin concentrations 
were reached after 5 minutes. Glucagon (1 nmovL) ele- 
vated the cyclic adenosine monophosphate (CAMP)  and 
inositol triphosphate (InsP,) levels in Kupffer cells about 
fivefold and twofold, respectively. The increase in glyco- 
gen phosphorylase activity elicited by l nmol/L glucagon 
was about twice as large in monocultures of hepatocytes 
than in cocultures of hepatocytes and Kupffer ceUs with 
the same hepatocyte density. Treatment of  cocultures 
with 500 pmoVL acetylsalicylic acid (MA)  to irreversibly 
inhibit cyclooqgenase (PGH-synthase) 30  minutes be- 
fore addition  of  glucagon  abolished  this  difference. 
These data support the hypothesis that PGs produced 
by Kupffer cells in response to glucagon might partici- 
pate in a feedback loop inhibiting glucagon-stimulated 
glycogenolysis  in  hepatocytes.  (HEPATOLOGY  1995;22: 
1577-1583.) 
Abbreviations: PG, prostaglandin; CAMP,  cyclic adenosine monophosphate; 
NCS, newborn calf serum; IBMX, isobutyl-methyl-xanthine;  ASA, acetylsali- 
cylic acid; cPLA,,  cytosolic phosphilase Az;  Inspa,  inositol trisphosphate. 
From the Institut fur Biochemie und Molekulare Zellbiologie, Georg-Au- 
gust-Universitat, Gottingen, Germany. 
Received April 26, 1995; accepted July 20, 1995. 
Supported  by  the  Deusche  Forschungsgemeinschaft, Bonn,  Germany, 
through the SFB 236, Teilprojekt All  and A24, and  later  Sonderforschungsber- 
eich 402, Teilprojekt B4 and B6. 
Address reprint requests to: Gerhard P. Puschel, MD, Institut fur Bio- 
chemie und Molekulare Zellbiologie,  Humboldtallee 23, 37073 Gottingen, Ger- 
many. 
Copyright 0  1995 by  the American  Association  for the Study of  Liver 
Diseases. 
0270-9139/95/2205-0033$3.00/0 
Prostaglandins (PGs) produced by  nonparenchymal 
liver  are involved in the regulation of liver car- 
bohydrate metabolism. They mediate the mobilization 
of  glucose from the liver in response to inflammatory 
~timuli,~  e.g.,  zymo~an,~  endotoxins,6 immune  com- 
ple~es,~  platelet  activating factor,'  and anaphylotox- 
ins.g  PGs increased inositol triphosphate (InsP,) forma- 
tion,  glycogen  phosphorylase  activity,  and  glucose 
output  in hepatocyte  cultures  and  suspensions.10-12 
This glycogenolytic effect was mediated by PGFzu  re- 
ceptors and PGE2  receptors of the EP1 subtype that are 
linked to phospholipase C by a pertussis toxin-insensi- 
tive G-protein.12 In addition, primarily PGEz and to a 
lesser  extent  also  PGF2,  and  PGDz  inhibited  the 
glucagon-stimulated cyclic adenosine monophosphate 
(CAMP)  formation,',  glycogen phosphorylase activity,12 
glucose mobilization from gly~ogen,'~,~~  and gluconeo- 
genesis12  in hepatocytes. This glucagon-antagonistic ef- 
fect was mediated by PGE2 receptors of  the EP3 sub- 
type,12 that  are  linked  to  adenylate  cyclase  by  a 
pertussis toxin-sensitive Gi-protein.16-l'  Therefore, PGs 
especially PGE2,  may be involved in a feedback inhibi- 
tion of glucagon-stimulated glucose mobilization from 
hepatocytes, if PGs were formed in a glucagon-depen- 
dent manner in the liver. 
Because glucagon receptors have been detected on 
Kupffer cells in binding studies,19  it appeared possible 
that they might be involved in a glucagon-stimulated 
PG formation and thus the proposed feedback loop. The 
current study provides evidence for such a mechanism: 
glucagon stimulated PG formation in Kupffer cells and 
caused a greater increase in glycogenolysis in hepato- 
cyte monocultures than in hepatocyteKupffer cell CO- 
cultures. 
MATERIALS AND METHODS 
Materials. All chemicals were of analytical grade and from 
commercial sources. [3H]Myoinositol and the radioimmuno- 
assays for PGEz,  PGFz,, PGD2,  and CAMP  were bought from 
Amersham (38110 Braunschweig, Germany), Dowex-formate 
from Serva (691  15 Heidelberg, Germany). The scintillation 
cocktail Hydroluma  was purchased  from Baker (Deventer, 
The Netherlands),  pronase  from Merck AG  (64293 Darm- 
stadt,  Germany)  and  collagenase,  and  deoxyribonuclease 
DNase from Boehringer (68305 Mannheim, Germany). Tis- 
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sue culture dishes were obtained from Nunc (65203 Wiesba- 
den,  Germany), Nycodenz  from  Life  Technologies  GmbH 
(76344 Eggenstein, Germany), Percoll from Pharmacia Bio- 
tech GmbH (79021 Freiburg, Germany), newborn calf serum 
(NCS) and bis-benzimide  from Sigma Chemical Co. (82041 
Deisenhofen,  Germany),  RPMI  1640  from  Biochrom  KG 
(12247 Berlin, Germany), and M199 from Gibco BRL (76344 
Eggenstein, Germany). 
Animals. Male Wistar rats (350 to 450 g for the prepara- 
tion of  Kupffer cells and 200 to 250 g for the isolation  of 
hepatocytes) were bought from Winkelmann (33178 Borchen, 
Germany) and kept on a  12-hour day-night  rhythm (light 
from 7 AM to 7 PM) with free access to water and a rat stan- 
dard diet from Ssniff (59494 Soest, Germany) at least 2 weeks 
before the experiments. Animal care and the use of the ani- 
mals in this study were in compliance with the German Law 
on the rrotection of Animals. 
Kupffer Cell Preparation.  Nonparenchymal cells were pre- 
pared by a combined collagenase/pronase perfusion."."  Kupf- 
fer  cells were then purified  by  Nycodenz density-gradient 
centrifugation and subsequent centrifugal elutriation using 
a Beckman JE-6 elutriation rotor in a 5-21 Beckman centri- 
fuge. 
Hepatocyte Preparation. Hepatocytes  were  isolated  ac- 
cording to Meredith22 without the use of  collagenase as de- 
scribed previou~ly.~~  The liver was perfused without recircu- 
lation via the portal vein with a Ca2+-free  Krebs-Henseleit 
buffer containing 15 mmol/L glucose, 2 mmol/L lactic acid, 
0.2 mmol/L sodium pyruvate and 2 mmol/L ethylenediamine- 
tetraacetic  acid. Detritus was removed  by  two  subsequent 
washing steps, sedimenting the viable hepatocytes  at 50g. 
Viable hepatocytes  were further purified by centrifugation 
through a gradient with 58% Percoll. 
Kupffer  Cell Culture. Kupffer cells were plated (5 X  lo6/ 
plate) on 3.5-cm tissue culture plates with or without collagen 
coating in RPMI 1640 in the presence of 1%  penicillidstrepto- 
mycin and 30% NCS  for 72 hours before the experiment. 
Medium was changed every 24 hours. 
Hepatocyte Culture. Hepatocytes  were plated  (7  x  lo5/ 
plate) on collagen-coated 3.5-cm tissue culture plates in M199 
with 0.5 nmol/L insulin, 1%  penicillidstreptomycin and 30% 
NCS  for  24  hours  before  the experiment  with  a medium 
change after 4 hours. 
Coculture. For coculture with hepatocytes,  Kupffer cells 
were seeded (4 x 106/plate)  on collagen-coated, 3.5-cm culture 
plates in RPMI 1640 in the presence of 1%  penicillidstrepto- 
mycin and 30% NCS  for the first 48 hours. Medium  was 
changed  every 24 hours. After 48 hours, freshly prepared 
hepatocytes (7 x 105/plate)  were plated on top of the Kupffer 
cells. Cocultures were incubated in M199 with 0.5 nmol/L 
insulin, 1%  penicillidstreptomycin, and 30%  NCS for another 
24 hours with one medium change after 4 hours. 
Determination ofProstanoid  and CAMP  Formation in  Kupf- 
fer Cells. After  72  h  cells were  washed  three  times  with 
Hank's balanced salt solution (137 mmol/L NaC1, 5.4 mmol/ 
L KC1,  1.3 mmol/L CaClz, 0.8 mmol/L MgCl,,  4.2 mmol/L 
NaHCO,,  0.34 mmol/L Na2P04,  0.44 mmoVL  KH,PO,,  20 
mmol/L HEPES, and 5 mmol/L glucose, pH 7.4) to remove 
all residual serum and medium  and then preincubated  for 
10 minutes in the same buffer. Then glucagon was added to 
the final concentrations indicated. Samples of  the superna- 
tant were taken at different times and frozen immediately 
in liquid nitrogen for the later determination  of  prostanoid 
concentrations. PGFz,, PGDz, and PGEz were determined in 
the cell supernatants without further purification by radioim- 
munoassay according to the instructions of the manufacturer. 
At the end of the experiment, Kupffer cells were scraped off 
the dish for DNA determination in a fluorescence assay based 
on the intercalation of bis-benzimide into DNA.24  For deter- 
mination  of  CAMP formation,  Kupffer  cell  cultures  were 
treated similarly except that at the end of  a 2-minute incuba- 
tion  period,  after addition of  glucagon  or vehicle, medium 
was removed, and cells were shock-frozen in  liquid nitrogen. 
CAMP  was extracted from these cells with 500 pL 10 mmoVL 
HC1 containing 1  mmoVL isobutyl-methyl-xanthine (IBMX). 
CAMP was  determined  with  a  l"I-radioimmunoassay  ac- 
cording to the instructions of the supplier. 
Determination of InsP3 Formation in Kupffer Cells. After 
48 hours  of  culture, medium was replaced by inositol-free 
RPMI medium supplemented as described above containing 
in addition 10 pCi/mL [3H]myoinositol. Culture was contin- 
ued for another 24 hours to label inositol-phospholipids. Me- 
dium was removed, cells were washed five times with Hank's 
balanced salt solution, and then incubated for 10 minutes at 
37°C in the same buffer  containing in addition 10 mmoVL 
LiCl to inhibit degradation of inositol phosphates. Glucagon 
(1  nmoVL final concentration) was added. After 3 minutes, 
medium was removed and cells were frozen in liquid nitrogen. 
Inositol phosphates were extracted with 350 pL 7.5% TCA. 
Inositol phosphates were separated on Dowex formate 1  x 8 
as described previouslyz5;  briefly, TCA was removed from the 
samples by 3 extractions with a 10-fold volume of ethylether. 
The water phase was diluted fourfold and applied to 1.5 mL 
(moist volume) Dowex formate in a small column. Inositol 
and inositol phosphates were eluted subsequently with 6 mL 
HzO (inositol), 4 mL 0.18 mom  ammonium formate (unchar- 
acterized inositol-containing compounds), 3 mL 0.4 mom  am- 
monium formate/O.l mom  formic acid (InsP), 3 mL 0.9 mol/ 
L ammonium formate/O.l mom  formic acid (InsP2),  and 1.5 
mom  ammonium formate/O.l mom  formic acid (Imp3);  1  mL 
eluate fractions were collected and counted in a scintillation 
counter with  10 mL Hydroluma.  Columns were calibrated 
with authentic inositol phosphate standards. 
Determination of  Glycogen Phosphorylase Activity in  Mono- 
cultures and Cocultures. Hepatocyte, Kupffer cell, and hepa- 
tocyteKupffer  cell cultures were washed  three times with 
HEPES-buffered saline (20 mmol/L Hepes, 120 mmol/L NaCl, 
4.8 mmol/L KC1,  1.2 mmoVL  MgS04, 1.2 mmol/L KH2P04, 
2.5 mmol/L CaClz, 5 mmol/L glucose, 2 mmol/L lactate, and 
0.2 mmom pyruvate, pH 7.4). Cells were incubated for 10 
minutes at 37°C in the same buffer. Then the medium was 
discarded  and replaced by 200 pL HEPES-buffered  saline 
with glucagon (final concentration 1  nmol/L), PGEz  (final con- 
centration 10 pmol/L), or both. After 2 minutes of incubation 
the buffer was removed, and the plates were frozen in liquid 
nitrogen. To inhibit the cyclooxygenase (PGH-synthase) cell 
cultures were pretreated with 500 pmol/L acetylsalicylic acid 
(ASA) in M199 30 minutes before the experiment.  Control 
plates were  incubated  with  M199 without ASA.  Glycogen 
phosphorylase  activity  was  determined  with  a  standard 
assay.26 
RESULTS 
Stimulation by Glucagon of  PG Formation in Kupffer 
Cells. In Kupffer cells that had been cultured for 72 
hours on untreated plastic dishes, glucagon (10 nmoV 
L) increased the formation of PGEz,  PGFz,, and PGDz. 
The increase was rapid in onset and transient, so that 
the PG concentrations in the medium  remained  in- 
creased over a period of  10 minutes (Fig. 1).  The in- 
crease was dose-dependent; concentrations of glucagon HEPATOLOGY  Vol. 22, No. 5, 1995  HESPELING,  JUNGERMA", AND  PUSCHEL  1579 
0th 
I". 
60 
40 
20 
0 
02  46  a10 
Time (min) 
FIG.  1.  Time dependence of  glucagon-stimulated  PG formation 
in  Kupffer  cells. Rat Kupffer  cells were prepared by  collagenase/ 
pronase liver perfusion, Nycodenz gradient centrifugation, and sub- 
sequent centrifugal elutriation. They were cultured for 72 hours on 
uncoated tissue culture plates. Medium was changed every 24 hours. 
Medium was replaced by a HEPES-buffered balanced salt solution. 
After a preincubation  period of  10 minutes, cells were stimulated 
with 1  nmoliL glucagon. At the times indicated, aliquots of the super- 
natant were taken and used without further purification for PG de- 
termination by radioimmunoassay.  Values (increase over zero-time 
levels) are means -C  SEM of 4  independent experiments. 
that are known to stimulate glycogenolysis in hepato- 
cytes and that can occur in portal blood, i.e., 0.1 to 1 
nmol/L, already enhanced PG formation nearly to the 
maximum (Fig. 2). Glucagon also increased PG forma- 
tion in Kupffer cells cultured on collagen-coated plates 
to the same extent as on uncoated tissue culture plates 
(not shown). 
Kupffer cells were treated with acetylsalicylic acid 
(ASA) (500 pmoVL) for 30 minutes. ASA was then re- 
moved.by three washes, and the cells incubated an- 
other 10 minutes without ASA. They were then stimu- 
lated with 1  nmol/L glucagon. Under these conditions 
basal PG formation was reduced to less than detection 
limit, and PG formation was no longer stimulated by 
glucagon (not shown). 
Glucagon (1 nmoVL) increased CAMP formation in 
Kupffer cells fivefold over basal within 2 minutes (Ta- 
ble  1). In Kupffer cells that had been  labelled with 
[3H]myoinositol  for 24 hours, glucagon (1 nmol/L) in- 
creased [3H]inositol-trisphosphate formation in pres- 
ence of  10 mmoVL  LiCl twofold  over basal within  3 
minutes (Table 1). In contrast to zymosan, no further 
increase in InsP, formation was observed during pro- 
longed incubation (not shown). 
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FIG.  2.  Dose dependence of  glucagon-stimulated  PG formation 
in Kupffer cells. The experiments were performed as in Fig. 1. Five 
minutes after glucagon addition aliquots  of  the supernatant were 
obtained and used without further purification for PG determination 
by radioimmunoassay.  Values  (increase over  zero-time levels) are 
means 2  SEM of  4 independent experiments. 1580  HESPELING,  JUNGERMANN, AND PUSCHEL 
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TABLE  1.  Glucagon-Stimulated Formation of CAMP 
and InsP, in Kupffer Cells 
CAMP (nM)  InsP, (CPM) 
Control  1.5 ? 0.3  173 2  20 
Glucagon (1  nM)  8.5 i  1.6*  334 ? 36* 
NOTE. Kupffer cells were cultured for a total of  72 hours. For 
determination of InsP, formation 10 pmol/L [3Hl-inositol was added 
to the culture medium. Medium was replaced by a HEPES-buffered 
Hank's  balanced salt solution that contained in addition 10 mmol/L 
LiCl for InsPs determination. After  10 minutes preincubation  cells 
were stimulated with glucagon, buffer was removed after 2 minutes 
(CAMP)  or 3 minutes (InsP,), and cells were frozen in liquid nitrogen. 
CAMP was  determined in the cell lysates by  radioimmunoassay, 
InsP,  by separation of  radioactively labeled inositol phosphates on 
Dowex formate columns. Values are means 2 SEM of  four (CAMP) 
and 3 (InsP,) experiments. Statistics: Student's t-test for paired sam- 
ples. 
*P  < .05. 
Stimulation by Glucagon of  Glycogen Phosphorylase 
Activity in  HepatocytelKupffer  Cell Cocultures. To test 
the working hypothesis that PGs released from Kupffer 
cells in response  to glucagon might feedback inhibit 
glucagon-stimulated  glycogen  phosphorylase  activity 
in hepatocytes, a coculture system of Kupffer cells and 
hepatocytes was established. 
Kupffer cells were cultured on collagen-coated cul- 
ture dishes for 48  hours. Then hepatocytes were seeded 
on top of the Kupffer cells. Culture was continued for 
another 24 hours before the experiment. Parallel to 
Kupffer cellhepatocyte cocultures, Kupffer cell mono- 
cultures  and  hepatocyte  monocultures  were  main- 
tained on collagen-coated culture dishes (Fig. 3).  There 
was no difference in morphology of hepatocytes in co- 
cultures and monocultures. Kupffer cells in cocultures 
seemed to contain somewhat more phagocytosed mate- 
rial, probably debris of  dead hepatocytes. Cocultures 
contained the same number of hepatocyteddish as con- 
trol hepatocyte monocultures and the same number of 
Kupffer cellddish as control Kupffer cell monocultures. 
The DNA content in cocultures (13.5  pg/dish) was about 
the sum of  the DNA content in Kupffer cell (3.7 pg/ 
dish) and hepatocyte (8.5 pg/dish) monocultures (Fig. 
3). Thus, it could be assumed that between 60% and 
70%  of the total DNA of cocultures were to be ascribed 
to hepatocyte  DNA. For  all further calculations  the 
fraction of hepatocyte DNA in cocultures was set equal 
to 65%. 
When  related  to  hepatocyte  DNA, basal  glycogen 
phosphorylase  activity  was  identical  in  hepatocyte 
monocultures and hepatocyte/Kupffer cell cocultures 
(1.86  +-  0.24  U  x  mg  hepatocyte  DNA-'  vs.  1.89 
t  0.26 U  x mg hepatocyte DNA-l). Glucagon stimu- 
lated  glycogen phosphorylase  activity  in hepatocyte 
monocultures by threefold over basal. Yet, in hepato- 
cytemupffer cell cocultures, glucagon increased glyco- 
gen phosphorylase activity only by twofold over basal 
(Fig. 4).  There was no appreciable degradation of gluca- 
gon either in hepatocyte monocultures or hepatocyte/ 
Kupffer cell cocultures during the course of the experi- 
ment (not shown). PGE, added concomitantly with glu- 
cagon, reduced the glucagon-stimulated glycogen phos- 
phorylase activity in hepatocyte monocultures by 25%. 
However, addition of  PGE, did not further reduce the 
glucagon effect in hepatocyteKupffer  cell cocultures 
(Fig. 4). Thus, it seemed possible that endogenously 
released PGs attenuated the glucagon-stimulated gly- 
cogen phosphorylase activity in cocultures. 
To corroborate this hypothesis, cell cultures were in- 
cubated with 500 pmol/L ASA for 30  minutes. This 
treatment completely and irreversibly inactivated PGH 
FIG.  3.  HepatocyteKupffer cell cocultures. Rat Kupffer cells were prepared as in Fig.  1 and cultured for 48 hours on collagen-coated 
tissue culture dishes. Medium was changed every 24 hours. Hepatocytes were prepared by calcium-free ethylenediaminetetraacetic acid 
liver perfusion without the use of  collagenase. They were purified by Percoll gradient centrifugation  and either seeded on top of Kupffer 
cell cultures or on separate collagen-coated culture dishes. Culture was continued for another 24 hours with a medium change after 4 hours. 
The DNA content was determined by a fluorometric assay. HEPATOLOGY  Vol. 22, No. 5, 1995  HESPELING,  JUNGERMA",  AND  PUSCHEL  1581 
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FIG.  4.  Stimulation by glucagon of glycogen phosphorylase activ- 
ity in hepatocyte  cultures and hepatocyteKupffer cell cocultures. 
Hepatocyte and Kupffer cell cultures as well as hepatocyteKupffer 
cell cocultures were prepared and maintained for 72 hours as in Fig. 
3. Medium was then replaced by fresh serum-free  medium containing 
500 kmoVL ASA when indicated. Cells were incubated for 30 minutes 
and medium replaced by a HEPES-buffered balanced salt solution. 
After  a preincubation  period  of  10 minutes, cells were stimulated 
with 1  nmol/L glucagon or 10 ,umol/L PGE,  or both. After 2 minutes, 
buffer was removed and cells were frozen in liquid nitrogen for later 
determination of glycogen phosphorylase in a standard assay. Values 
are means t  SEM of four independent experiments. HC, hepatocyte 
mono-culture; Cocu, hepatocyteKupffer cell co-culture; G, glucagon; 
E, PGE,.  Statistics: Student's  t-test for  unpaired  samples,  (a) P 
< .01; (b)  P < .05. 
synthases in Kupffer cells (see previously). ASA  was 
then removed, and after another 10 minutes, cell cul- 
tures were stimulated with glucagon. In ASA-treated 
hepatocyte monocultures  and hepatocyteKupffer  cell 
cocultures, basal glycogen phosphorylase activity was 
somewhat less than in untreated cultures (1.56 ? 0.26 
U  X  mg hepatocyte DNAp1 and 1.44 ? 0.21 U  X  mg 
hepatocyte DNAp1). In ASA-treated, as in untreated 
hepatocyte monocultures, glucagon increased glycogen 
phosphorylase activity by threefold. However, in con- 
trast to untreated cocultures, glucagon increased glyco- 
gen phosphorylase activity in ASA-treated hepatocyte/ 
Kupffer cell cocultures also by threefold (Fig. 4). Thus, 
ASA  treatment abolished the difference of  glucagon- 
stimulated  glycogen  phosphorylase  activity  between 
hepatocyte monocultures  and hepatocyteKupffer  cell 
cocultures. Surprisingly, ASA treatment also abolished 
the attenuation by PGE2 of  glucagon-stimulated glyco- 
gen  phosphorylase  activity  in  hepatocyte  monocul- 
tures.  This effect is not  understood  and most  likely 
cannot be ascribed to  the inactivation of PGH synthase. 
DISCUSSION 
Functional Role of  the Glucagon Receptor on Kupffer 
Cells. Glucagon receptors have previously been shown 
on Kupffer cells by electron microscopy using glucagon 
that had been cross-linked to  gold particles via albumin 
and also in [12511glucagon-binding  studies."  The elec- 
tron microscopical studies showed that glucagon recep- 
tors were internalized via a clathrin-independent path- 
way and that the endocytotic vesicles were fused with 
lysosomes. Therefore, glucagon receptors on Kupffer 
cells have  been  implicated  in intrahepatic  glucagon 
degradation; however, only a minor fraction (20%) of 
['2511glucagon  was degraded by Kupffer cells in suspen- 
sion within 1  hour at 37"C.l' Similarly, in the current 
study, no appreciable  glucagon degradation could be 
observed in Kupffer cell cultures within  2 minutes. 
Therefore, the role of Kupffer cells in glucagon degrada- 
tion is doubtful. Thus, the glucagon-elicited PG release 
shown in the current study (Figs. 1  and 2) appears to 
be the first example for a physiological role of glucagon 
receptors on Kupffer cells. 
Mechanism  of  the  Glucagon-Induced PG  Release 
From Kupffer Cells. The glucagon receptor appears to 
be  coupled to two intracellular  signalling pathways; 
the ligand occupied receptor stimulates the adenylate 
cyclase and also increases the cytosolic Ca2+  concentra- 
tion and InsP, formati~n.~~,~~  Accordingly, glucagon in- 
creased both CAMP  formation by fivefold and InsPs for- 
mation by twofold in Kupffer cells (Table 1).  In previous 
studies glucagon was found to only slightly increase 
CAMP formation in Kupffer cells. This increase was 
very small compared with the increase in total liver 
plasma membranes."  In purified Kupffer cell plasma 
membranes, no increase in adenylate cyclase activity 
in response to glucagon could be dete~ted.~'  In the older 
studies, it remained  unclear  what the physiological 
meaning of the glucagon-dependent increase in CAMP 
could be. Later, extracellularly applied dibutyryl CAMP 
was shown to attenuate zymosan-stimulated and phor- 
bol ester-stimulated  but not calcium ionophore-stim- 
ulated PG formation by about 50%.,'  The increase in 
CAMP  formation that is also elicited by PGs in Kupffer 
cells has been implicated as a possible negative feed- 
back loop of PG f~rmation.~'  Glucagon would thus elicit 
an inhibitory signal for PG formation in Kupffer cells. 
However, protein  kinase A-dependent  phosphoryla- 
tion of cytosolic phospholipase A2 (cPLA2)  has also been 
shown to activate this key regulatory enzyme of arachi- 
donic acid and thus PG synthesi~,~~~~~  even though the 
increase in activity was small compared with activation 
with MAP kina~e.,~  Therefore, it seems to be possible 
that the glucagon-mediated increase in CAMP forma- 
tion in Kupffer cells could also increase basal PG forma- 
tion. In line with this hypothesis, dibutyl CAMP  applied 
in high concentrations (1  mmol/L) to Kupffer cell cul- 1582  HESPELING,  JUNGERMA",  AND  PUSCHEL  HEPATOLOGY  November 1995 
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FIG. 5.  Model of  the glucagon-elicited feedback inhibition by PG 
production in Kupffer cells of the glucagon-stimulated glycogenolysis 
in hepatocytes. ACY, adenylate cyclase; dashed lines, indirect regula- 
tion or multistep reaction; EP,-R, PGE, receptor of the EP, subtype; 
G,, heterotrimeric inhibitory G protein; Go, phospholipase C  -linked 
heterotrimeric  G protein; G-R = glucagon receptor; G,  = heterotri- 
meric stimulatory G protein; HC, hepatocyte; KC, Kupffer cell; PL, 
phospholipid; solid lines, direct regulation or one step reaction. 
tures increased PG formation (Hespeling,  Unpublished 
observation, February 1995). 
On the other hand, activation  of  phospholipase  C 
with the generation of DAG and InsPs seems to be one 
mechanism by  which PG formation can be enhanced 
in Kupffer cells33  both directly and indirectly via the 
activation  of  cPLA,.  Glucagon could thus initiate a 
stimulatory signal for prostaglandin formation also by 
these pathways. 
Functional Significance of the Glucagon-Induced PG 
Formation  in Kupffer  Cells. PGs,  primarily  PGE,, 
have been shown to attenuate glucagon-stimulated gly- 
cogenolysis  in  hepatocytes.  The  PG  concentrations 
needed to inhibit glucagon-stimulated glycogen phos- 
phorylase activity or glucose mobilization ranged from 
20 to 200  The prostaglandin concentra- 
tion in portal and hepatovenous blood, however, is only 
in the range of  1  nmol/L. Thus, to be operative in a 
hypothetical feedback inhibition loop, prostaglandins 
must be formed locally in the vicinity of hepatocytes in 
response to glucagon and reach the neighboring hepa- 
tocytes through paracrine diffusion not via the circula- 
tion. The current study provides evidence for such a 
hypothesis: glucagon-stimulated prostaglandin forma- 
tion in Kupffer cells (Figs. l and 2) may be one possible 
intrahepatic source for the prostaglandins needed in 
the feedback loop. 
Moreover, the study shows that glucagon-stimulated 
glycogenolysis was partially attenuated in a hepato- 
cytemupffer cell coculture system and that this attenu- 
ation could be abolished by aspirin treatment of Kupf- 
fer cellshepatocyte cocultures (Fig. 4). This indicates 
that prostaglandins produced by Kupffer cells may in- 
deed act on nearby hepatocytes in a paracrine mecha- 
nism to attenuate glucagon-stimulated glycogenolysis. 
In addition to the inhibition of PGH-synthase, aspi- 
rin inhibited  the attenuation of glucagon-stimulated 
glycogenolysis by externally added PGEz (Fig. 4). The 
mechanism of the aspirin action is almost certainly not 
caused by the inhibition of PGH synthase (cyclooxygen- 
ase). It is possible that aspirin interferes with the sig- 
nal chain of the PGE, receptor involved, but the site of 
interference  is  currently  not  known.  Other  PGH 
synthase inhibitors like indomethacin, ibuprofen, and 
piroxicam also attenuated the inhibition by  PGE,  of 
glucagon-stimulated  glycogenolysis  in  hepatocytes 
(Hespeling, Unpublished  data, February, 1995).34  In 
addition, indomethacin and ibuprofen stimulated gly- 
cogenolysis in hepatocytes.  Thus, the mechanism  of 
abolishment by aspirin of the inhibitory action of exoge- 
nous PGEz on the glucagon-dependent glycogenolysis 
remains to be defined. 
Conclusion. The current study provides evidence for 
the following model (Fig. 5):  glucagon stimulates glyco- 
genolysis in hepatocytes. At the same time glucagon 
enhances PG formation in Kupffer cells. In turn, PGs, 
especially PGE, ,  inhibit the glucagon-stimulated glyco- 
genolysis in hepatocytes; thereby, glucagon can feed- 
back  inhibit  its  own  stimulatory  signal  on  hepatic 
glycogenolysis  by  an  intercellular  communication 
mechanism  between  nonparenchymal and parenchy- 
mal cells. 
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